Cargando…
Pharmacokinetic Characterization of LW6, a Novel Hypoxia-Inducible Factor-1α (HIF-1α) Inhibitor in Mice
LW6, an (aryloxyacetylamino)benzoic acid derivative, was recently identified to be an inhibitor of hypoxia-inducible factor-1α (HIF-1α), which is an attractive target for cancer therapeutics. Although LW6 is known to act by inhibiting the accumulation of HIF-1α, pharmacokinetics needs to be evaluate...
Autores principales: | Lee, Ji-Yoon, Lee, Kiho, Lee, Kyeong, Kang, Jong Soon, Kim, Min Ju, Yoo, Dong Gu, Kim, Jung Ah, Shin, Eun Jin, Oh, Soo Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070284/ https://www.ncbi.nlm.nih.gov/pubmed/33921487 http://dx.doi.org/10.3390/molecules26082226 |
Ejemplares similares
-
Metabolite Profiling and Characterization of LW6, a Novel HIF-1α Inhibitor, as an Antitumor Drug Candidate in Mice
por: Lee, Kiho, et al.
Publicado: (2021) -
The disubstituted adamantyl derivative LW1564 inhibits the growth of cancer cells by targeting mitochondrial respiration and reducing hypoxia-inducible factor (HIF)-1α accumulation
por: Kim, Inhyub, et al.
Publicado: (2020) -
NQO1 inhibits proteasome-mediated degradation of HIF-1α
por: Oh, Eun-Taex, et al.
Publicado: (2016) -
Docetaxel induced-JNK2/PHD1 signaling pathway increases degradation of HIF-1α and causes cancer cell death under hypoxia
por: Oh, Eun-Taex, et al.
Publicado: (2016) -
Suppression of Akt-HIF-1α signaling axis by diacetyl atractylodiol inhibits hypoxia-induced angiogenesis
por: Choi, Sik-Won, et al.
Publicado: (2016)